Those who need in-person care or frequent live visits Those who want to use insurance for name-brand GLP-1s Anyone with a history of thyroid cancer, pancreatitis, or significant GI issues
The range of available treatments featuring each unique GLP1 receptor antagonist adds depth to the arsenal against obesity by presenting distinct advantages relevant across different circumstances within patient care scenariosfor instance, innovative outcomes demonstrated by Tirzepatide or anticipated results from forthcoming therapies like Retatrutide and Cagrilintide signal an expanding horizon within pharmacological interventions aimed at achieving substantial weight loss results while upholding effective glucose balance measures
How do GLP-1 medications like Ozempic or Wegovy affect glucose levels
Stopping Treatment Too Soon Its common for people to stop taking GLP-1 medications once theyve reached their target weight, assuming the job is done
These medications stimulate the pancreas to release insulin in response to meals, helping patients achieve stable glucose levels
Retatrutide goes one step further because it acts on glucagon (GCG) receptors as well, which also have a role in how hungry you feel
